Filip Swirski, PhD, an internationally recognized leader in cardiovascular immunology research, is the inaugural Director of the new Cardiovascular Research Institute. Dr. Swirski intends to build on Mount Sinai’s legacy of discovery and innovation with a renewed focus on lifestyle and prevention, systems physiology and bioengineering, and genetic medicine.
